Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct 1;80(4):763-765.
doi: 10.1097/HEP.0000000000000898. Epub 2024 Apr 19.

Clonal hematopoiesis of indeterminate potential and risk of hepatocellular carcinoma: New kids on the block

Affiliations
Editorial

Clonal hematopoiesis of indeterminate potential and risk of hepatocellular carcinoma: New kids on the block

Yi-Te Lee et al. Hepatology. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest:

Hsian-Rong Tseng is employed by and owns stock in Eximus Diagnostics. He owns stock in CytoLumina and Pulsar. Ju Dong Yang consults for AstraZeneca, Eisai, Exact, Excelixis, Fujifilm, Gilead, and Merck. The remaining author has no conflicts to report.

Comment on

References

    1. Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature reviews. Gastroenterology & hepatology 2019;16:589–604. - PMC - PubMed
    1. Lee YT, Wang JJ, Luu M, Tseng HR, Rich NE, Lu SC, Nissen NN, et al. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States. Hepatology 2021;74:1384–1394. - PubMed
    1. Karim MA, Singal AG, Kum HC, Lee YT, Park S, Rich NE, Noureddin M, et al. Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in the United States. Clin Gastroenterol Hepatol 2023;21:670–680.e618. - PMC - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73–84. - PubMed
    1. Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology (Baltimore, Md.) 2018;67:123–133. - PMC - PubMed